A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.

Intermediate-stage hepatocellular carcinoma (HCC), defined according to the Barcelona Clinic Liver Cancer (BCLC) staging system, is a heterogeneous condition with variable clinical benefits from transarterial chemoembolization (TACE). This study aimed to develop a simple validated prognostic score b...

Full description

Bibliographic Details
Main Authors: Sadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka, Naoya Kanogawa, Tenyu Motoyama, Eiichiro Suzuki, Akinobu Tawada, Ryosaku Azemoto, Masami Shinozaki, Masaharu Yoshikawa, Osamu Yokosuka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4412579?pdf=render

Similar Items